From TradingView · · 1m 20s
A bullish Bat setup on Stryker
A trader spots a harmonic Bat pattern completing on Stryker, with a tight stop at $249 and targets stretching past $450.
In brief
A trader spots a harmonic Bat pattern completing on Stryker, with a tight stop at $249 and targets stretching past $450. The whole trade hinges on $249 holding. Below that, the Bat pattern is dead and so is the thesis. Originally reported by TradingView.
A Bat is completing on SYK

Stryker is printing a bullish Bat pattern, and price is now sliding into the Potential Reversal Zone between $262 and $275.
“SYK is showing a bullish Bat pattern on the chart, with price now approaching the Potential Reversal Zone”
The zone sits on support

What makes the setup interesting is location. The Bat finishes right where an existing support area already sits, so two signals line up in the same place.
“This is an interesting setup because the Bat is completing near an important support area.”
The trade, in numbers

Entry between $262 and $275. Stop loss at $249. Targets step up through $329, $355 and $377, with a stretch goal above $450.
“Entry: $262, $275 Stop: $249 Targets: $329 → $355 → $377 → $450+”
$329 is the first test
The first major target is $329. Reclaiming it with real momentum is what puts $355 and $377 in play, rather than just on the chart.
“If SYK can reclaim that level with momentum, the next targets at $355 and $377 come into focus.”
Why the risk math works
The pattern hands you a defined invalidation point instead of a guess, and the upside targets are far enough away to pay for that small risk.
“the Bat gives us a clearly defined risk level at $249, while the upside targets provide a strong potential risk-to-reward opportunity”
$249 is the off switch
Patterns fail. A decisive break below $249 weakens the whole bullish case, which is exactly why the stop lives there and not lower.
“As always, the pattern can fail, so the $249 level is important.”
The essence
The whole trade hinges on $249 holding. Below that, the Bat pattern is dead and so is the thesis.





